With a degree in Mechanical Engineering and Industrial Organization and a Master in Business Innovation, Marc Rafat worked in the automotive and industrial machinery sector for 15 years. When his wife died of cancer, though, he left it all to move into the healthcare sector. After doing the d·HEALTH Barcelona fellowship, promoted by Biocat, he founded his own business, HealthQuay, through which he aspires to help other oncology patients.
She studied Psychology and a Master in Health Research at the Autonomous University of Barcelona (UAB). After some years as a researcher at the Hospital del Mar Research Institute, in 2008 she co-founded HumanITcare, a platform to monitor patients’ healthcare information, where she is currently CEO.
She studied Physics at the University of Barcelona and got her PhD in this field in 2003. Throughout her career, however, she has focused on electronic micro devices and, in recent years, micro electrochemical power sources. She is currently an ICREA professor at the Barcelona Microelectronics Institute.
PhD in Neurogenetics and Neuroscience from the University of Barcelona and Baylor College of Medicine in Houston. He did his postdoc in the US and, in 2017, moved to the Institute of Research Germans Trias I Pujol (IGTP), where he heads up the Neurogenetics Research Unit. After extensive experience as a project coordinator, peer reviewer for science journals and business adviser in Spain and abroad, in 2018 he co-founded the spin-off Biointaxis to develop treatments for Friedreich Ataxia and other minority neurological diseases.
Samantha López has a degree in Biology and a master in Biostatistics and Bioinformatics, with experience in molecular biology and data analysis. Oliver Balcells has a degree in Business Administration and an MBA, experience in finance and venture capital. Joan Grasas has degrees in Telecommunications engineering and Market research and a master in Engineering Management and international Business Administration, and experience in Business Management and Innovation. These three profiles came together to co-found RheoDX, where they are currently the CSO, CEO and CPO, respectively.
In 2017, he finished his PhD at Hospital La Paz in Madrid, analyzing immune response in several diseases, including sepsis. He published more than 25 papers in 5 years but decided to pivot his career by joining the d·HEALTH Barcelona program promoted by Biocat. During the program, he did a clinical immersion at Institut Guttmann, where he came up with the idea that has led to his start-up: Loop Dx.